214 related articles for article (PubMed ID: 28148775)
1. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.
Salta E; De Strooper B
FASEB J; 2017 Feb; 31(2):424-433. PubMed ID: 28148775
[TBL] [Abstract][Full Text] [Related]
2. Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.
Meng F; Dai E; Yu X; Zhang Y; Chen X; Liu X; Wang S; Wang L; Jiang W
J R Soc Interface; 2014 Mar; 11(92):20131057. PubMed ID: 24352679
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.
Satoh J
J Pharmacol Sci; 2010; 114(3):269-75. PubMed ID: 20953120
[TBL] [Abstract][Full Text] [Related]
4. The Role of miR-124 in Drosophila Alzheimer's Disease Model by Targeting Delta in Notch Signaling Pathway.
Kong Y; Wu J; Zhang D; Wan C; Yuan L
Curr Mol Med; 2015; 15(10):980-9. PubMed ID: 26592243
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer's Disease (AD)-Novel and Unique Pathological Features.
Zhao Y; Pogue AI; Lukiw WJ
Int J Mol Sci; 2015 Dec; 16(12):30105-16. PubMed ID: 26694372
[TBL] [Abstract][Full Text] [Related]
6. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
Kong Y; Wu J; Yuan L
Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
[TBL] [Abstract][Full Text] [Related]
8. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).
Pogue AI; Lukiw WJ
Cell Mol Neurobiol; 2018 Jul; 38(5):1021-1031. PubMed ID: 29302837
[TBL] [Abstract][Full Text] [Related]
9. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
Nunomura A; Perry G
Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
Dehghani R; Rahmani F; Rezaei N
Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Dysregulation in Alzheimer's Disease.
Putteeraj M; Fairuz YM; Teoh SL
CNS Neurol Disord Drug Targets; 2017; 16(9):1000-1009. PubMed ID: 28782488
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the microRNA network during the progression of Alzheimer's disease.
Lau P; Bossers K; Janky R; Salta E; Frigerio CS; Barbash S; Rothman R; Sierksma AS; Thathiah A; Greenberg D; Papadopoulou AS; Achsel T; Ayoubi T; Soreq H; Verhaagen J; Swaab DF; Aerts S; De Strooper B
EMBO Mol Med; 2013 Oct; 5(10):1613-34. PubMed ID: 24014289
[TBL] [Abstract][Full Text] [Related]
14. Addressing Alzheimer's Disease (AD) Neuropathology Using Anti-microRNA (AM) Strategies.
Jaber VR; Zhao Y; Sharfman NM; Li W; Lukiw WJ
Mol Neurobiol; 2019 Dec; 56(12):8101-8108. PubMed ID: 31183807
[TBL] [Abstract][Full Text] [Related]
15. microRNA Isolation, Expression Profiling, and Target Identification for Neuroprotection in Alzheimer's Disease.
Iqbal S; Pal D
Methods Mol Biol; 2024; 2761():277-290. PubMed ID: 38427244
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
Swarbrick S; Wragg N; Ghosh S; Stolzing A
Mol Neurobiol; 2019 Sep; 56(9):6156-6167. PubMed ID: 30734227
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease.
Schonrock N; Matamales M; Ittner LM; Götz J
Exp Neurol; 2012 Jun; 235(2):447-54. PubMed ID: 22119426
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D
Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNA-485 in neurodegenerative diseases.
Ryu IS; Kim DH; Cho HJ; Ryu JH
Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
